Fermenta Biotec.

{
  "main_header": {
    "sid": 261671,
    "name": "Fermenta Biotec.",
    "stock_name": "Fermenta Biotec.",
    "full_name": "Fermenta Biotech Ltd",
    "name_url": "stocks-analysis/fermenta-biotec",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "350.00",
    "chg": 8.5,
    "chgp": "2.49%",
    "dir": 1,
    "prev_price": "341.50",
    "mcapval": "1,007.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 506414,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE225B01021",
    "curr_date": "Mar 20",
    "curr_time": "",
    "bse_nse_vol": "39.7 k",
    "exc_status": "Active",
    "traded_date": "Mar 20, 2026",
    "traded_date_str": "2026 03 20",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/fermenta-biotec-261671-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Why is Fermenta Biotech Ltd falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-fermenta-biotech-ltd-fallingrising-3899461",
        "imagepath": "",
        "date": "2026-03-19 01:20:13",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Outperformance Against Benchmarks</strong></p>\n<p>Fermenta Biotech’s recent price action stands out distinctly when compared to the broader market indices. Over the past week, the stock has appreciated by 2.81%, while the Sensex has marginally declined by 0.21%. This positive divergence extends over longer periods as well, with the stock gaining 5.73% in the last month against the Sensex’s 8.40% fall. Year-to-date, Fermenta Biotech has marginally declined by 0.56%, a performance that is still significantly better than the Sensex’s near 10% drop. Over the one-year horizon, the stock has surged by an impressive 40.84%, far outpacing the Sensex’s modest 1.86% gain. Even over three years, Fermenta Biotech’s returns of 154.17% dwarf the Sensex’s 32.27%, highlighting the company’s sustained growth..."
      },
      {
        "title": "Fermenta Biotech Ltd: Valuation Shift Enhances Price Attractiveness Amid Sector Challenges",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/fermenta-biotech-ltd-valuation-shift-enhances-price-attractiveness-amid-sector-challenges-3895508",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/FermentaBiotech_valuationdot_3895508.png",
        "date": "2026-03-17 08:00:16",
        "description": "Fermenta Biotech Ltd has witnessed a notable improvement in its valuation parameters, shifting from a very attractive to an attractive rating, signalling a renewed price appeal for investors amid a mixed sector backdrop. Despite a recent downgrade in its overall Mojo Grade to Sell, the micro-cap pharmaceutical and biotechnology company’s valuation metrics suggest a compelling entry point relative to peers and historical averages."
      },
      {
        "title": "Fermenta Biotech Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/fermenta-biotech-ltd-technical-momentum-shifts-amid-mixed-market-signals-3892588",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/FermentaBiotech_technicaldot_3892588.png",
        "date": "2026-03-16 08:00:32",
        "description": "Fermenta Biotech Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a subtle shift in its technical momentum, reflected in a downgrade of its Mojo Grade from Hold to Sell as of 29 January 2026. Despite a recent mild bullish trend on daily moving averages, the stock’s broader technical indicators present a complex picture, signalling caution for investors amid a 4.81% decline in the latest trading session."
      },
      {
        "title": "Fermenta Biotech Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/fermenta-biotech-ltd-is-rated-sell-3892214",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/FermentaBiotech_mojoScore_3892214.png",
        "date": "2026-03-15 10:10:02",
        "description": "Fermenta Biotech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 09 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 15 March 2026, providing investors with an up-to-date view of the company's fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Fermenta Biotech Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/fermenta-biotech-ltd-is-rated-sell-3869048",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/FermentaBiotech_mojoScore_3869048.png",
        "date": "2026-03-04 10:10:02",
        "description": "Fermenta Biotech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 09 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 04 March 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Fermenta Biotech Gains 0.65%: 3 Key Factors Driving the Week’s Mixed Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/fermenta-biotech-gains-065-3-key-factors-driving-the-weeks-mixed-momentum-3862719",
        "imagepath": "",
        "date": "2026-02-28 17:06:59",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>Feb 23:</strong> Stock surges 3.68% on valuation upgrade</p>\n                    <p><strong>Feb 24:</strong> Continued gains amid mixed Sensex performance</p>\n                    <p><strong>Feb 25:</strong> Bullish technical momentum confirmed with 1.16% rise</p>\n                    <p><strong>Feb 26-27:</strong> Profit booking leads to declines of 2.25% and 2.14%</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.335.15</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.325.35</div><div..."
      },
      {
        "title": "Fermenta Biotech Ltd Technical Momentum Shifts Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/fermenta-biotech-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-3859485",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/FermentaBiotech_technicaldot_3859485.png",
        "date": "2026-02-27 08:00:28",
        "description": "Fermenta Biotech Ltd has experienced a notable shift in its technical momentum, transitioning from a bullish to a mildly bullish trend as of late January 2026. Despite a recent downgrade in its Mojo Grade from Hold to Sell, the stock’s technical indicators present a complex picture, with mixed signals from MACD, RSI, moving averages, and other momentum oscillators. This analysis delves into the nuances of these technical parameters to provide investors with a comprehensive understanding of the stock’s current positioning within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Fermenta Biotech Ltd Sees Bullish Momentum Amid Mixed Technical Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/fermenta-biotech-ltd-sees-bullish-momentum-amid-mixed-technical-signals-3854587",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/FermentaBiotech_technicaldot_3854587.png",
        "date": "2026-02-25 08:00:47",
        "description": "Fermenta Biotech Ltd has witnessed a notable shift in its technical momentum, transitioning from a mildly bullish to a bullish trend, reflecting renewed investor interest despite mixed signals from key indicators such as MACD and RSI. The stock’s recent price action, combined with evolving technical parameters, suggests a cautiously optimistic outlook for this Pharmaceuticals & Biotechnology player amid broader market dynamics."
      },
      {
        "title": "Fermenta Biotech Ltd Valuation Shift Signals Renewed Price Attractiveness",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/fermenta-biotech-ltd-valuation-shift-signals-renewed-price-attractiveness-3851924",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/FermentaBiotech_valuationdot_3851924.png",
        "date": "2026-02-24 08:00:29",
        "description": "Fermenta Biotech Ltd has recently undergone a notable shift in its valuation parameters, moving from a very attractive to an attractive rating. This change reflects evolving market perceptions amid a backdrop of solid financial metrics and mixed returns relative to the broader Sensex index. Investors are now reassessing the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios in comparison to historical averages and peer benchmarks within the Pharmaceuticals & Biotechnology sector."
      }
    ],
    "total": 539,
    "sid": "261671",
    "stock_news_url": "https://www.marketsmojo.com/news/fermenta-biotech-261671"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "28-Feb-2026",
      "details": "Publication of notice for Special window for transfer and dematerialisation of physical securities",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "19-Feb-2026",
      "details": "Intimation of investor meeting.",
      "source": "BSE"
    },
    {
      "caption": "Intimation Of Investor Presentation - Q3/9Mofy26",
      "datetime": "11-Feb-2026",
      "details": "Intimation of Investor Presentation - Q3/9moFY26",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Fermenta Biotech Ltd has declared <strong>50%</strong> dividend, ex-date: 06 Aug 25",
          "dt": "2025-08-06",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Fermenta Biotech Ltd has announced <strong>5:5</strong> stock split, ex-date: 08 Aug 18",
          "dt": "2018-08-08",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Fermenta Biotech Ltd has announced <strong>2:1</strong> bonus issue, ex-date: 13 Feb 20",
          "dt": "2020-02-13",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Why is Fermenta Biotech Ltd falling/rising?

2026-03-19 01:20:13

Outperformance Against Benchmarks

Fermenta Biotech’s recent price action stands out distinctly when compared to the broader market indices. Over the past week, the stock has appreciated by 2.81%, while the Sensex has marginally declined by 0.21%. This positive divergence extends over longer periods as well, with the stock gaining 5.73% in the last month against the Sensex’s 8.40% fall. Year-to-date, Fermenta Biotech has marginally declined by 0.56%, a performance that is still significantly better than the Sensex’s near 10% drop. Over the one-year horizon, the stock has surged by an impressive 40.84%, far outpacing the Sensex’s modest 1.86% gain. Even over three years, Fermenta Biotech’s returns of 154.17% dwarf the Sensex’s 32.27%, highlighting the company’s sustained growth...

Read full news article

Fermenta Biotech Ltd: Valuation Shift Enhances Price Attractiveness Amid Sector Challenges

2026-03-17 08:00:16

Fermenta Biotech Ltd has witnessed a notable improvement in its valuation parameters, shifting from a very attractive to an attractive rating, signalling a renewed price appeal for investors amid a mixed sector backdrop. Despite a recent downgrade in its overall Mojo Grade to Sell, the micro-cap pharmaceutical and biotechnology company’s valuation metrics suggest a compelling entry point relative to peers and historical averages.

Read full news article

Fermenta Biotech Ltd Technical Momentum Shifts Amid Mixed Market Signals

2026-03-16 08:00:32

Fermenta Biotech Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a subtle shift in its technical momentum, reflected in a downgrade of its Mojo Grade from Hold to Sell as of 29 January 2026. Despite a recent mild bullish trend on daily moving averages, the stock’s broader technical indicators present a complex picture, signalling caution for investors amid a 4.81% decline in the latest trading session.

Read full news article

Fermenta Biotech Ltd is Rated Sell

2026-03-15 10:10:02

Fermenta Biotech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 09 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 15 March 2026, providing investors with an up-to-date view of the company's fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Fermenta Biotech Ltd is Rated Sell

2026-03-04 10:10:02

Fermenta Biotech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 09 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 04 March 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Fermenta Biotech Gains 0.65%: 3 Key Factors Driving the Week’s Mixed Momentum

2026-02-28 17:06:59

Key Events This Week

Feb 23: Stock surges 3.68% on valuation upgrade

Feb 24: Continued gains amid mixed Sensex performance

Feb 25: Bullish technical momentum confirmed with 1.16% rise

Feb 26-27: Profit booking leads to declines of 2.25% and 2.14%

Week Open

Rs.335.15

Week Close

Rs.325.35

Read full news article

Fermenta Biotech Ltd Technical Momentum Shifts Amid Mixed Indicator Signals

2026-02-27 08:00:28

Fermenta Biotech Ltd has experienced a notable shift in its technical momentum, transitioning from a bullish to a mildly bullish trend as of late January 2026. Despite a recent downgrade in its Mojo Grade from Hold to Sell, the stock’s technical indicators present a complex picture, with mixed signals from MACD, RSI, moving averages, and other momentum oscillators. This analysis delves into the nuances of these technical parameters to provide investors with a comprehensive understanding of the stock’s current positioning within the Pharmaceuticals & Biotechnology sector.

Read full news article

Fermenta Biotech Ltd Sees Bullish Momentum Amid Mixed Technical Signals

2026-02-25 08:00:47

Fermenta Biotech Ltd has witnessed a notable shift in its technical momentum, transitioning from a mildly bullish to a bullish trend, reflecting renewed investor interest despite mixed signals from key indicators such as MACD and RSI. The stock’s recent price action, combined with evolving technical parameters, suggests a cautiously optimistic outlook for this Pharmaceuticals & Biotechnology player amid broader market dynamics.

Read full news article

Fermenta Biotech Ltd Valuation Shift Signals Renewed Price Attractiveness

2026-02-24 08:00:29

Fermenta Biotech Ltd has recently undergone a notable shift in its valuation parameters, moving from a very attractive to an attractive rating. This change reflects evolving market perceptions amid a backdrop of solid financial metrics and mixed returns relative to the broader Sensex index. Investors are now reassessing the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios in comparison to historical averages and peer benchmarks within the Pharmaceuticals & Biotechnology sector.

Read full news article

View All News